CIK 0001623526
- Non-accelerated filer
- Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471144582
- Phone
- +1 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $403,975
- in 4 filings, $404K under 10b5-1 plans
Net −$403,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-09 | Nash Huw M. COO & CBO | Sale | −17,201 | $30.00 | $516K | 0 |
| 2020-09-09 | Nash Huw M. COO & CBO | Exercise or conversion · Employee Stock Option (Right to Buy) | −17,201 | 161,611 | ||
| 2020-09-08 | Nash Huw M. COO & CBO | Exercise or conversion | +30,718 | $2.19 | $67K | 30,718 |
| 2020-09-08 | Nash Huw M. COO & CBO | Sale | −30,718 | $30.00 | $922K | 0 |
| 2020-09-08 | Nash Huw M. COO & CBO | Exercise or conversion · Employee Stock Option (Right to Buy) | −30,718 | 178,812 | ||
| 2020-09-01 | Nash Huw M. COO & CBO | Exercise or conversion | +5,700 | $2.19 | $12K | 5,700 |
| 2020-09-01 | Nash Huw M. COO & CBO | Sale | −5,000 | $27.60 | $138K | 700 |
| 2020-09-01 | Nash Huw M. COO & CBO | Sale | −700 | $28.71 | $20K | 0 |
| 2020-09-01 | Nash Huw M. COO & CBO | Exercise or conversion · Employee Stock Option (Right to Buy) | −5,700 | 209,530 | ||
| 2020-08-28 | Nash Huw M. COO & CBO | Exercise or conversion | +2,081 | $2.19 | $5K | 2,081 |
| 2020-08-28 | Nash Huw M. COO & CBO | Sale | −2,081 | $30.00 | $62K | 0 |
| 2020-08-28 | Nash Huw M. COO & CBO | Exercise or conversion · Employee Stock Option (Right to Buy) | −2,081 | 215,230 | ||
| 2020-08-13 | Menzel Garry E Director | Grant or award · Director Stock Option (Right to Buy) | +29,555 | 29,555 | ||
| 2020-08-03 | Nash Huw M. COO & CBO | Exercise or conversion | +5,700 | $2.19 | $12K | 5,700 |
| 2020-08-03 | Nash Huw M. COO & CBO | Sale | −5,700 | $24.73 | $141K | 0 |
| 2020-08-03 | Nash Huw M. COO & CBO | Exercise or conversion · Employee Stock Option (Right to Buy) | −5,700 | 217,311 | ||
| 2020-07-16 | Nash Huw M. COO & CBO | Exercise or conversion | +1,900 | $2.19 | $4K | 1,900 |
| 2020-07-16 | Nash Huw M. COO & CBO | Sale | −1,900 | $25.06 | $48K | 0 |
| 2020-07-16 | Nash Huw M. COO & CBO | Exercise or conversion · Employee Stock Option (Right to Buy) | −1,900 | 223,011 | ||
| 2020-07-07 | Walker Robin A. Chief Legal Officer, CCO & Sec | Sale | −941 | $22.50 | $21K | 0 |
Page 30 of 35 · 681 trades